These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23168827)

  • 1. Effective treatment of traumatic brain injury: learning from experience.
    Ruff RL; Riechers RG
    JAMA; 2012 Nov; 308(19):2032-3. PubMed ID: 23168827
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citicoline for traumatic brain injury: report of two cases, including my own.
    Spiers PA; Hochanadel G
    J Int Neuropsychol Soc; 1999 Mar; 5(3):260-4. PubMed ID: 10217926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.
    Poole NA; Agrawal N
    Brain Inj; 2008 Jul; 22(7-8):519-34. PubMed ID: 18568705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of donepezil in the treatment of cognitive impairments of moderate traumatic brain injury.
    Foster M; Spiegel DR
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):106. PubMed ID: 18305293
    [No Abstract]   [Full Text] [Related]  

  • 7. Citicoline. Monograph.
    Altern Med Rev; 2008 Mar; 13(1):50-7. PubMed ID: 18377103
    [No Abstract]   [Full Text] [Related]  

  • 8. Citicoline: pharmacological and clinical review, 2010 update.
    Secades JJ
    Rev Neurol; 2011 Mar; 52 Suppl 2():S1-S62. PubMed ID: 21432836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is citicoline for acute ischaemic stroke?
    Hankey GJ
    Lancet; 2012 Jul; 380(9839):318-20. PubMed ID: 22691568
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selection of neuromethabolic drug in severe brain injury].
    Zaĭtsev OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):66-9. PubMed ID: 21246892
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats.
    Dempsey RJ; Raghavendra Rao VL
    J Neurosurg; 2003 Apr; 98(4):867-73. PubMed ID: 12691414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting Past Proof of Concept For New Treatments.
    Perlis RH
    Am J Psychiatry; 2015 Oct; 172(10):937-8. PubMed ID: 26423476
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular and clinical aspects of the effect of cytidyndiphosphocholine on cognitive functions].
    Gromova OA; Torshin IY; Grishina TR; Demidov VI; Bogacheva TE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(5):88-97. PubMed ID: 34184483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline, use in cognitive decline: vascular and degenerative.
    García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
    J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perspectives on the treatment of organic mental disorders by the use of nootropic agents].
    Litvintsev SV; Shamreĭ VK; Reznik AM; Arbuzov AL
    Voen Med Zh; 2002 May; 323(5):59-62. PubMed ID: 12073844
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of citicoline on level of consciousness, serum level of fetuin-A and matrix Gla-protein (MGP) in trauma patients with diffuse axonal injury (DAI) and GCS≤8.
    Shokouhi G; Haghjoo AG; Sattarnezhad N; Asghari M; Sattarnezhad A; Asghari A; Pezeshki A
    Ulus Travma Acil Cerrahi Derg; 2014 Nov; 20(6):410-6. PubMed ID: 25541919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citicoline in stroke and TBI clinical trials.
    Adibhatla RM
    Nat Rev Neurol; 2013 Mar; 9(3):173. PubMed ID: 23358483
    [No Abstract]   [Full Text] [Related]  

  • 19. Poststroke pharmacotherapy: another ictus.
    Goldstein LB
    Stroke; 2012 Dec; 43(12):3433-5. PubMed ID: 23138442
    [No Abstract]   [Full Text] [Related]  

  • 20. Stroke: Treatment for acute stroke--the end of the citicoline saga.
    Clark WM; Clark TD
    Nat Rev Neurol; 2012 Sep; 8(9):484-5. PubMed ID: 22868867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.